NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $339,000 | -65.2% | 1,529 | -79.2% | 0.00% | -75.0% |
| Q1 2021 | $973,000 | -79.5% | 7,358 | -73.2% | 0.00% | -80.0% |
| Q4 2020 | $4,750,000 | -12.9% | 27,453 | -43.9% | 0.02% | -20.0% |
| Q3 2020 | $5,451,000 | -52.8% | 48,968 | -74.9% | 0.02% | -55.4% |
| Q2 2020 | $11,559,000 | +204.7% | 194,923 | +246.0% | 0.06% | +133.3% |
| Q1 2020 | $3,793,000 | +116.6% | 56,328 | +171.0% | 0.02% | +166.7% |
| Q4 2019 | $1,751,000 | +152.7% | 20,783 | +124.3% | 0.01% | +125.0% |
| Q3 2019 | $693,000 | -49.7% | 9,265 | -57.5% | 0.00% | -42.9% |
| Q2 2019 | $1,378,000 | +34.3% | 21,799 | +2.3% | 0.01% | +16.7% |
| Q1 2019 | $1,026,000 | -46.0% | 21,299 | -41.2% | 0.01% | -40.0% |
| Q3 2018 | $1,899,000 | +67.5% | 36,244 | 0.0% | 0.01% | +66.7% |
| Q2 2018 | $1,134,000 | – | 36,244 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |